KCT0005586Recruiting未知
A multi-center, randomized, investigator-initiated trial to evaluate the efficacy of PRreservation of ovArian function, Hemostasis, and sAfety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 19(Year) to 45(Year) (—)
- Sex
- Female
Inclusion Criteria
- •Informed consent.
- •Age: 19-45 year-old women
- •American Society of Anesthesiologists Physical Status classification 1 or 2
- •Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
- •Regular menstruation every 21-45 days
Exclusion Criteria
- •No ‘ovarian’ endometriosis
- •Suspicious disease of ovarian malignancy
- •Age: 18 and younger, 46 and older
- •Pregnancy or breastfeeding.
- •Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
- •Hormonal therapy within recent 3 months
- •Considered as inappropriate by the researcher's judgment.
Investigators
Similar Trials
Active, not recruiting
Phase 1
An investigator-initiated, multi-center, randomized, double-blind, placebo controlled study of Dupilumab to demonstrate efficacy in subjects with nummular eczemaSubjects with nummular eczemaMedDRA version: 20.0Level: PTClassification code 10012431Term: DermatitisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2019-003162-41-DEKlinikum rechts der Isar, Technische Universität München70
Terminated
Phase 4
Pilot phase for the Tension-type HeadAche Prevention Project (HAPPy Too) to investigate in a double-blind, randomised trial whether treatment with low-dose blood pressure (BP) lowering therapy on top of standard care will reduce tension-type headache compared to placebo and standard care.Tension-type HeadacheACTRN12617001323314The George Institute for Global Health120
Terminated
Phase 4
Pilot phase for the workplace migraine HeadAche Prevention Project (HAPPy - pilot) to investigate in a double blind randomised factorial trial whether treatment with low-dose combination blood pressure (BP) and cholesterol lowering therapy will reduce migraine compared to standard therapy and placebo.Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)MigraineACTRN12616000937415The George Institute for Global Health180
Active, not recruiting
Phase 1
Efficacy, safety, tolerability, and pharmacokinetics of MIJ821 inpatients with treatment-resistant depressioEUCTR2018-003002-12-ESovartis Farmacéutica, S.A.70
Active, not recruiting
Phase 1
A phase II study to evaluate CSJ148 in pregnant women with primary HCMV infectioEUCTR2017-002047-15-DEovartis Pharma AG120